Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001049107-09-000014
Filing Date
2009-05-18
Accepted
2009-05-18 16:13:06
Documents
5
Period of Report
2009-01-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K ihbt10k13109.htm 10-K 1894763
2 EXHIBIT 14.1 ihbt10k13109ex14_1.htm EX-14.1 12437
3 EXHIBIT 21.1 ihbt10k13109ex21_1.htm EX-21.1 974
4 EXHIBIT 31.1 ihbt10k13109ex31_1.htm EX-31.1 14933
5 EXHIBIT 32.1 ihbt10k13109ex32_1.htm EX-32.1 7557
  Complete submission text file 0001049107-09-000014.txt   1932167
Mailing Address 7315 EAST PEAKVIEW AVENUE CENTENNIAL CO 80111
Business Address 7315 EAST PEAKVIEW AVENUE CENTENNIAL CO 80111 303-796-8940
INHIBITON THERAPEUTICS, INC. (Filer) CIK: 0001108046 (see all company filings)

EIN.: 880448626 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-K | Act: 34 | File No.: 333-57946 | Film No.: 09836861
SIC: 2834 Pharmaceutical Preparations